Group structure
9 companies in 6 countries
Loading your page…
Loading your page…
9 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
25 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Ivabradine Chanelle Medical 5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2017 |
| Ivabradine Chanelle Medical 5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2017 |
| Ivabradine Chanelle Medical 7,5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2017 |
| Ivabradine Chanelle Medical 7,5 mg filmomhulde tablettenFilmomhulde tablet | Ivabradine | Netherlands | Authorised | 2017 |
| Memantine Chanelle 10 mg/ml drankDrank | Memantine | Netherlands | Authorised | 2013 |
| Rualalit 20mg/ml, druppels voor oraal gebruik, oplossingDruppels voor oraal gebruik, oplossing | Escitalopram | Netherlands | Authorised | 2013 |
| BISOLOL 10 mg Tablet | Bisoprolol | Saudi Arabia | Authorised | |
| BISOLOL 2.5 mg Tablet | Bisoprolol | Saudi Arabia | Authorised | |
| BISOLOL 5 mg Tablet | Bisoprolol | Saudi Arabia | Authorised | |
| CHANAZINE 100MG INJECTION100 mg / ml · Liquid | Xylazine | Canada | Authorised | |
| CLINACIN150 mg · Tablet | Clindamycin | Canada | Marketed | 2006 |
| CLINACIN75 mg · Tablet | Clindamycin | Canada | Marketed | 2006 |
| CLINACIN25 mg · Tablet | Clindamycin | Canada | Marketed | 2006 |
| CLINACIN SOLUTION25 mg / ml · Solution | Clindamycin | Canada | Marketed | 2016 |
| FANVIL | Vardenafil | Saudi Arabia | Authorised | |
| FENOFLOX 50 MG/ML SOLUTION FOR INJECTION50 mg / ml · Solution | Enrofloxacin | Canada | Authorised | |
| INFLACAM CHEWABLE TABLETS1 mg · Tablet (Chewable) | Meloxicam | Canada | Marketed | 2019 |
| INFLACAM CHEWABLE TABLETS2.5 mg · Tablet (Chewable) | Meloxicam | Canada | Marketed | 2019 |
| INFLACAM INJECTION5 mg / ml · Solution | Meloxicam | Canada | Marketed | 2020 |
| KLENDAM | Clindamycin | Saudi Arabia | Authorised | |
| Kurenail | Amorolfina | Saudi Arabia | Authorised | |
| RHEUMOCAM 1.5MG/ML ORAL SUSPENSION FOR DOGS1.5 mg / ml · Suspension | Meloxicam | Canada | Marketed | 2012 |
| RHEUMOCAM 15 MG/ML ORAL SUSPENSION15 mg / ml · Suspension | Meloxicam | Canada | Marketed | 2021 |
| RHEUMOCAM INJECTION5 mg / ml · Solution | Meloxicam | Canada | Marketed | 2015 |
| RHEUMOCAM INJECTION20 mg / ml · Solution | Meloxicam | Canada | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 13 | 13 | 0 | CompaniesAll medicines |
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Saudi Arabia | 6 | 6 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.